c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells

Molecular Pharmacology

Volumn 60, Issue 1, 2001, Pages 174-182

  Biroccio, Annamaria ^a   Benassi, Barbara ^a   Amodei, Sarah ^a   Gabellini, Chiara ^a   Del Bufalo, Donatella ^a   Zupi, Gabriella ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CAMPTOTHECIN; CASPASE 3; CASPASE INHIBITOR; CISPLATIN; DOXORUBICIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RNA;

APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA REPAIR; DRUG CYTOTOXICITY; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA CELL; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0034948497     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.1.174     Document Type: Article

References (39)

1. Apoptotic cell death induced by c-myc is inhibited by bcl-2
2. Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells
3. c-Myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice
4. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
5. Myc: A single gene controls both proliferation and apoptosis in mammalian cells
6. Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system
7. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells
8. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard
9. Oncogene-dependent apoptosis in extracts from drug-resistant cells
10. Apoptosis in cancer therapy: Crossing the threshold
11. Cellular accumulation of the anticancer agent cisplatin: A review
12. Mitochondria and apoptosis
13. Mediation of c-Myc-induced apoptosis by p53
14. Bcl-2 functions as an anti-oxidant pathway to prevent apoptosis
15. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
16. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA
17. Reactive oxygen species are downstream mediators of p53-dependent apoptosis
18. Involvement of CPP32/caspase-3 in c-Myc-induced apoptosis
19. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
20. Resistance to 195mPt-radiolabeled cis-diaminedichloroplatinum(II) of shock cells transfected with various oncogenes
21. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells
22. The proto-oncogene Bcl-2 and its role in regulating apoptosis
23. Mitochondrial control of apoptosis
24. Immunohistochemical expression of c-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma
25. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
26. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin
27. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice
28. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells
29. Myc function and regulation
30. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line
31. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells
32. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene
33. Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins
34. Myc oncogenes and human neoplastic disease
35. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand
36. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms
37. Modulation of cisplatinum resistance in Friend erythroleukemia cells by c-myc
38. The regulation of reactive oxygen species production during programmed cell death
39. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase